Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.64
4.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dividends
Dividend Yield
Hubei Biocause Pharmaceutical Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Hubei Biocause Pharmaceutical Co Ltd
Payout Ratio
Hubei Biocause Pharmaceutical Co Ltd
Current Payout | |
Min Payout | |
Max Payout | |
Average Payout | |
Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Debt Paydown
Not Applicable
Due to the unique financial structures and regulatory environments of banks and insurance companies, the Debt Paydown metric is not applicable for Hubei Biocause Pharmaceutical Co Ltd.
These institutions manage liabilities differently, focusing more on regulatory compliance and operational liabilities than traditional debt management, making standard debt paydown calculations irrelevant.
Price Appreciation
Price
Hubei Biocause Pharmaceutical Co Ltd
Average Annual Return | -14.99% |
Standard Deviation of Annual Returns | 17.96% |
Max Drawdown | -76% |
Market Capitalization | 20.8B CNY |
Shares Outstanding | 4 940 630 016 |
Percentage of Shares Shorted |
N/A
|